Serological status for HBV and HCV infection in anti-HIV seropositive and seronegative intravenous drug abusers.
De Mercato
R
R
Istituto di Medicina Pubblica e della Sicurezza Sociale; Facoltà di Medicina, Università di Napoli.
Oriani
G
G
Guarnaccia
D
D
Romano
A
A
Ciampi
R
R
Cantiello
J P
JP
Di Pietro
M
M
Celentano
U
U
Riganti
C
C
Romano
C
C
D000328:Adult; D015483:HIV Antibodies / Q000097:blood; D015658:HIV Infections / Q000150:complications*; D006679:HIV Seropositivity / Q000150:complications*; D006508:Hepatitis Antibodies / Q000097:blood*; D006509:Hepatitis B / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D006526:Hepatitis C / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D008297:Male; D012725:Sexual Behavior; D015819:Substance Abuse, Intravenous / Q000150:complications*
D015483:HIV Antibodies; D006508:Hepatitis Antibodies